The host immune response to tuberculosis.

[1]  A. Sette,et al.  Differential effects of cytolytic T cell subsets on intracellular infection. , 1997, Science.

[2]  J. Keane,et al.  Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis , 1997, Infection and immunity.

[3]  S. Tonegawa,et al.  Contribution of α/β and γ/δ T lymphocytes to immunity against Mycobacterium bovis Bacillus Calmette Guérin: studies with T cell receptor‐deficient mutant mice , 1995 .

[4]  R. Crystal,et al.  Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. , 1991, The Journal of clinical investigation.

[5]  J. Abrams,et al.  γδ T Lymphocytes in Human Tuberculosis , 1992 .

[6]  R. Riley,et al.  Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. 1959. , 1959, American journal of epidemiology.

[7]  V. Aber,et al.  Virulence and resistance to superoxide, low pH and hydrogen peroxide among strains of Mycobacterium tuberculosis. , 1978, Journal of general microbiology.

[8]  P. Andrew,et al.  In vitro interaction of Mycobacterium tuberculosis and macrophages: activation of anti-mycobacterial activity of macrophages and mechanisms of anti-mycobacterial activity. , 1996, Current topics in microbiology and immunology.

[9]  W. Rom,et al.  Copyright © 1997, American Society for Microbiology Effects of Mycobacteria on Regulation of Apoptosis in , 1997 .

[10]  N. Hibler,et al.  Arrest of Mycobacterial Phagosome Maturation Is Caused by a Block in Vesicle Fusion between Stages Controlled by rab5 and rab7* , 1997, The Journal of Biological Chemistry.

[11]  T. Kotsimbos,et al.  IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis. , 1997, American journal of respiratory and critical care medicine.

[12]  J. Abrams,et al.  Cytokine production at the site of disease in human tuberculosis , 1993, Infection and immunity.

[13]  P. Barnes,et al.  Clinical Correlates of Interferon γ Production in Patients with Tuberculosis , 1997 .

[14]  P. D'Arcy Hart,et al.  Ammonia inhibits phagosome–lysosome fusion in macrophages , 1980, Nature.

[15]  Z. Toossi,et al.  In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. Kuo,et al.  Relation of bronchoalveolar lavage T lymphocyte subpopulations to rate of regression of active pulmonary tuberculosis. , 1995, Thorax.

[17]  F. Mosteller,et al.  Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature , 1994 .

[18]  Z. Balikó,et al.  Gamma/delta T lymphocytes in Mycobacterium tuberculosis infection. , 1997, Thorax.

[19]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[20]  W. Rom,et al.  Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. , 1996, American journal of respiratory and critical care medicine.

[21]  W. Rom,et al.  Thalidomide Treatment Reduces Tumor Necrosis Factor α Production and Enhances Weight Gain in Patients with Pulmonary Tuberculosis , 1995, Molecular medicine.

[22]  S. Kaufmann,et al.  Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates , 1991, Infection and immunity.

[23]  W. Schaefer,et al.  Lipids of Putative Relevance to Virulence in Mycobacterium tuberculosis: Phthiocerol Dimycocerosate and the Attenuation Indicator Lipid , 1974, Infection and immunity.

[24]  R. Steinman,et al.  Dendritic cells: antigen presentation, accessory function and clinical relevance. , 1993, Advances in experimental medicine and biology.

[25]  M. Troye-Blomberg,et al.  Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens. , 1994, Immunology.

[26]  Dinakar,et al.  T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. , 1994, The Journal of clinical investigation.

[27]  V. Jarlier,et al.  [Analysis of restriction fragment length polymorphism (RFLP) of Mycobacterium tuberculosis strains isolated from patients with several episodes of tuberculosis]. , 1996, Pathologie-biologie.

[28]  D. Valeyre,et al.  Characterization of γ/δ T-Lymphocytes in the Peripheral Blood of Patients with Active Tuberculosis: A Comparison with Normal Subjects and Patients with Sarcoidosis , 1992 .

[29]  A. Falk,et al.  Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII. , 1978, Chest.

[30]  M. Gately,et al.  Interleukin 12 at the site of disease in tuberculosis. , 1994, The Journal of clinical investigation.

[31]  J. Convit,et al.  Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. , 1991, Science.

[32]  D. Alland,et al.  Improved outcomes for patients with multidrug-resistant tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  W W Stead,et al.  Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. , 1985, The New England journal of medicine.

[34]  J. Hartley,et al.  Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection , 1995, Clinical and experimental immunology.

[35]  W. Winkelstein.  A new perspective on John Snow's communicable disease theory. , 1995, American journal of epidemiology.

[36]  F. Gambón-Deza,et al.  Lymphocyte populations during tuberculosis infection: V beta repertoires , 1995, Infection and immunity.

[37]  E. Medina,et al.  Evidence inconsistent with a role for the Bcg gene (Nramp1) in resistance of mice to infection with virulent Mycobacterium tuberculosis , 1996, The Journal of experimental medicine.

[38]  L. Schlesinger,et al.  Binding of the terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages. , 1994, Journal of immunology.

[39]  B. Bloom,et al.  Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages , 1992, The Journal of experimental medicine.

[40]  M. Piacentini,et al.  APOPTOSIS OF HUMAN MONOCYTES/MACROPHAGES IN MYCOBACTERIUM TUBERCULOSIS INFECTION , 1997, The Journal of pathology.

[41]  D. Adams.  The structure of mononuclear phagocytes differentiating in vivo. I. Sequential fine and histologic studies of the effect of Bacillus Calmette-Guerin (BCG). , 1974, The American journal of pathology.

[42]  I. Stříž,et al.  Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis. , 1995, Chest.

[43]  P. Coffer,et al.  Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-gamma involves binding of distinct factors to a palindromic response element. , 1994, The Journal of biological chemistry.

[44]  M. Yalcin,et al.  IL-8 in pleural effusion. , 1996, Respiratory medicine.

[45]  T. Lee,et al.  Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components. , 1993, The Journal of clinical investigation.

[46]  L. Schlesinger.  Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. , 1993, Journal of immunology.

[47]  R. Shafer,et al.  Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. , 1993, The New England journal of medicine.

[48]  M. Emoto,et al.  Functions of T-cell subsets and cytokines in mycobacterial infections. , 1995, The European respiratory journal. Supplement.

[49]  B. Balbi,et al.  Tuberculous pleural effusions. Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. , 1987, The American review of respiratory disease.

[50]  D. Voelker,et al.  Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. , 1995, Journal of immunology.

[51]  J. Flynn,et al.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Ellner,et al.  T-Cell Responses and Cytokines , 1994 .

[53]  H. Kuo,et al.  Increased production of hydrogen peroxide and expression of CD11b/CD18 on alveolar macrophages in patients with active pulmonary tuberculosis. , 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[54]  M. Nowakowski,et al.  Different distributions of lung and blood lymphocyte subsets in pediatric AIDS or tuberculosis. , 1992, Annals of clinical and laboratory science.

[55]  S. Kaufmann,et al.  Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages , 1997, Infection and immunity.

[56]  R. Steinman,et al.  Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages. , 1993, Science.

[57]  F. Annunziato,et al.  Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease. , 1997, The American journal of pathology.

[58]  R. Rose,et al.  Growth inhibition of Mycobacterium avium complex in human alveolar macrophages by the combination of recombinant macrophage colony-stimulating factor and interferon-gamma. , 1991, American journal of respiratory cell and molecular biology.

[59]  E. Skamene.  The Bcg gene story. , 1994, Immunobiology.

[60]  D. Schellenberg,et al.  Antigenic specificity and subset analysis of T cells isolated from the bronchoalveolar lavage and pleural effusion of patients with lung disease , 1992, Clinical and experimental immunology.

[61]  W. Rom,et al.  Local immune responses correlate with presentation and outcome in tuberculosis. , 1998, American journal of respiratory and critical care medicine.

[62]  W. Stead.  Management of Health Care Workers after Inadvertent Exposure to Tuberculosis: A Guide for the Use of Preventive Therapy , 1995, Annals of Internal Medicine.

[63]  C. Kroegel,et al.  Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. , 1994, American journal of respiratory and critical care medicine.

[64]  C. W. Lee,et al.  Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis. , 1996, Journal of immunology.

[65]  W. Rom,et al.  Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. , 1996, American journal of respiratory and critical care medicine.

[66]  J. Phair,et al.  Airborne Contagion and Air Hygiene , 1955 .

[67]  A. Lykke,et al.  The cellular evolution of inflammatory granulomata. , 1966, The Journal of pathology and bacteriology.

[68]  L. García,et al.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls , 1994, Infection and immunity.

[69]  Z. Toossi,et al.  Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. , 1994, The Journal of infectious diseases.

[70]  J. Friedland.  Chemotactic cytokines and tuberculosis. , 1994, Biochemical Society transactions.

[71]  A. Izzo,et al.  Evidence for an alpha/beta T cell-independent mechanism of resistance to mycobacteria. Bacillus-Calmette-Guerin causes progressive infection in severe combined immunodeficient mice, but not in nude mice or in mice depleted of CD4+ and CD8+ T cells , 1992, The Journal of experimental medicine.

[72]  I. Orme,et al.  Chemokine response in mice infected with Mycobacterium tuberculosis , 1995, Infection and immunity.

[73]  D. Bishop,et al.  Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival? , 1997, Transplantation.

[74]  N. Boéchat,et al.  Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis , 1996, The Journal of experimental medicine.

[75]  H. Shiratsuchi,et al.  Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis , 1995, Infection and immunity.

[76]  M. Horwitz,et al.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. , 1990, Journal of immunology.

[77]  W. Boom,et al.  Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis , 1996, Infection and immunity.

[78]  Boom Wh.  The role of T-cell subsets in Mycobacterium tuberculosis infection. , 1996 .

[79]  H. Shiratsuchi,et al.  Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. , 1995, Journal of immunology.

[80]  R. Seder,et al.  Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses. , 1997, Journal of immunology.

[81]  P. Gros,et al.  Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus , 1995, Journal of leukocyte biology.

[82]  J. Armstrong,et al.  Prevention of phagosome-lysosome fusion in cultured macrophages by sulfatides of Mycobacterium tuberculosis. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[83]  J. Blackwell,et al.  Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Bcg gene story continues. , 1994, Immunology letters.

[84]  G. Kaplan,et al.  Sequestration of Mycobacterium tuberculosis in tight vacuoles in vivo in lung macrophages of mice infected by the respiratory route , 1997, Infection and immunity.

[85]  V. Kindler,et al.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection , 1989, Cell.

[86]  W. Stead,et al.  The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future. , 1997, Clinics in chest medicine.

[87]  S. Kishimoto,et al.  Increase of gamma/delta T cells in hospital workers who are in close contact with tuberculosis patients , 1994, Infection and immunity.

[88]  J. Kay,et al.  Isolation and characterization of beta-glucan receptors on human mononuclear phagocytes , 1991, The Journal of experimental medicine.

[89]  S. Wright,et al.  Interferon-gamma depresses binding of ligand by C3b and C3bi receptors on cultured human monocytes, an effect reversed by fibronectin , 1986, The Journal of experimental medicine.

[90]  Schlesinger Ls.  Role of mononuclear phagocytes in M tuberculosis pathogenesis. , 1996 .

[91]  R. Rees,et al.  ELECTRON MICROSCOPY OF THE HOST-CELL PARASITE RELATION IN MURINE LEPROSY. , 1965, The Journal of pathology and bacteriology.

[92]  D E Snider,et al.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. , 1995, JAMA.

[93]  N. Mor.  Intracellular location of Mycobacterium leprae in macrophages of normal and immune-deficient mice and effect of rifampin , 1983, Infection and immunity.

[94]  K. McDonough,et al.  Mycobacterium Tuberculosis. Virulence-associated Phenotype of Cytotoxicity for Lung Epithelial Cells Is A , 1995 .

[95]  P. Schlesinger,et al.  Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. , 1994, Science.

[96]  S. Porcelli,et al.  CDlb restricts the response of human CD4−8−T lymphocytes to a microbial antigen , 1992, Nature.

[97]  J. Abrams,et al.  T-cell cytokine responses in human infection with Mycobacterium tuberculosis , 1995, Infection and immunity.

[98]  R. Young,et al.  A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[99]  D. Mitchell,et al.  Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. , 1994, American journal of respiratory and critical care medicine.

[100]  W. Rom,et al.  Treatment of multidrug-resistant pulmonary tuberculosis with interferon-γ via aerosol , 1997, The Lancet.

[101]  F. Belardelli.  Role of interferons and other cytokines in the regulation of the immune response , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[102]  S. Romagnani,et al.  Understanding the role of Th1/Th2 cells in infection. , 1996, Trends in microbiology.

[103]  D. Lowrie,et al.  Killing of Mycobacterium microti by immunologically activated macrophages , 1981, Nature.

[104]  W. Rom,et al.  Human host response to Mycobacterium tuberculosis. , 1995, Swiss medical weekly.

[105]  M. Denis.  Killing of Mycobacterium tuberculosis within human monocytes: activation by cytokines and calcitriol , 1991, Clinical and experimental immunology.

[106]  W. Rom,et al.  Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. , 1996, Thorax.

[107]  R L Modlin,et al.  Th1-Th2 paradigm: insights from leprosy. , 1994, The Journal of investigative dermatology.

[108]  Jacqueline K. White,et al.  Genomic Organization and Sequence of the Human NRAMP Gene: Identification and Mapping of a Promoter Region Polymorphism , 1995, Molecular medicine.

[109]  A. Dannenberg.  Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis. , 1994, Immunobiology.

[110]  A. Gupta,et al.  Dysregulation of homeostasis of blood T-lymphocyte subpopulations persists in chronic multibacillary pulmonary tuberculosis patients refractory to treatment. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[111]  J. Ernst,et al.  Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. , 1996, American journal of respiratory cell and molecular biology.

[112]  W. Stead.  Genetics and Resistance to Tuberculosis , 1992, Annals of Internal Medicine.

[113]  A. Scheffold,et al.  P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues , 1997, Nature.

[114]  P. Barnes,et al.  Absence of a prominent Th2 cytokine response in human tuberculosis , 1996, Infection and immunity.

[115]  Z. Toossi,et al.  Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[116]  W. Rom,et al.  Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. , 1996, American journal of respiratory and critical care medicine.

[117]  B. Cronstein,et al.  Mycobacterium tuberculosis alters expression of adhesion molecules on monocytic cells , 1994, Infection and immunity.

[118]  B. Bloom,et al.  Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages , 1993 .

[119]  S. Das,et al.  IS6110 restriction fragment length polymorphism typing of clinical isolates of Mycobacterium tuberculosis from patients with pulmonary tuberculosis in Madras, south India. , 1995, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[120]  N. Mukaida,et al.  Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. , 1997, American journal of respiratory and critical care medicine.

[121]  L. Young,et al.  Mycobacterial diseases and the compromised host. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[122]  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[123]  S. Kaufmann,et al.  gamma/delta and other unconventional T lymphocytes: what do they see and what do they do? , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[124]  R. Williamson,et al.  Evidence for exclusion of a mutation in NRAMP as the cause of familial disseminated atypical mycobacterial infection in a Maltese kindred. , 1995, Journal of Medical Genetics.

[125]  J. Blackwell,et al.  Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. , 1996, Molecular medicine today.

[126]  I. Orme,et al.  Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.

[127]  J. Belisle,et al.  Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. , 1996, Journal of Immunology.

[128]  The Bcg Gene (Nrampl) Does Not Determine Resistance of Mice to Virulent Mycobacterium tuberculosis , 1996, Annals of the New York Academy of Sciences.

[129]  R. Mitchell.  Mortality and relapse of uncomplicated advanced pulmonary tuberculosis before chemotherapy: 1,504 consecutive admissions followed for fifteen to twenty-five years. , 1955, American review of tuberculosis.

[130]  G. Delespesse,et al.  In vitro maturation of naive human CD4+ T lymphocytes into Th1, Th2 effectors. , 1997, International archives of allergy and immunology.

[131]  J. Vilček,et al.  Mice That Lack the Interferon- 7 Receptor Have Profoundly Altered Responses to Infection with Bacillus Calmette-Gu6rin and Subsequent Ch-ilenge with Lipopolysaccharide By Ryutaro Kamijo,* Junming l.e,* Deborah Shapiro,* , 1993 .

[132]  F. Ruscetti,et al.  Pleiotropic Effects of Transforming Growth Factor‐β on Cells of the Immune System , 1993, Annals of the New York Academy of Sciences.

[133]  G. Rook,et al.  Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. , 1986, Immunology.

[134]  S. Kaufmann,et al.  Target cell lysis and IL-2 secretion by gamma/delta T lymphocytes after activation with bacteria. , 1990, Journal of immunology.

[135]  M. Torres,et al.  T lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. , 1996, The Journal of infectious diseases.

[136]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[137]  J. Vilček,et al.  Mycobacterium bovis infection of mice lacking receptors for interferon-gamma or for transcription factor IRF-1. , 1994, Journal of interferon research.

[138]  W. Boom,et al.  Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4+ and CD8+ cytotoxic T cells and relative resistance of alveolar macrophages to lysis. , 1997, Journal of immunology.

[139]  T. Byrd.  Tumor necrosis factor alpha (TNFalpha) promotes growth of virulent Mycobacterium tuberculosis in human monocytes iron-mediated growth suppression is correlated with decreased release of TNFalpha from iron-treated infected monocytes. , 1997, The Journal of clinical investigation.

[140]  S. Kaufmann,et al.  Mycobacterial growth inhibition by interferon-gamma-activated bone marrow macrophages and differential susceptibility among strains of Mycobacterium tuberculosis. , 1987, Journal of immunology.

[141]  S. Romagnani,et al.  The Th1/Th2 paradigm. , 1997, Immunology today.

[142]  E. Abe,et al.  Fusion and activation of human alveolar macrophages induced by recombinant interferon-gamma and their suppression by dexamethasone. , 1987, The American review of respiratory disease.

[143]  A. B. Kay,et al.  TH2‐Type Cytokines in Asthma , 1996, Annals of the New York Academy of Sciences.

[144]  G. Kaplan,et al.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin , 1994, The Journal of experimental medicine.

[145]  M. Zasloff,et al.  Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of a cDNA. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[146]  S. Vermund,et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. , 1989, The New England journal of medicine.

[147]  J. Flynn,et al.  Major histocompatibility complex class I-restricted T cells are necessary for protection against M. tuberculosis in mice. , 1993, Infectious agents and disease.

[148]  S. Kaufmann,et al.  Attempts to characterize the mechanisms involved in mycobacterial growth inhibition by gamma-interferon-activated bone marrow macrophages , 1988, Infection and immunity.

[149]  A. J. Crowle,et al.  Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria , 1985, Infection and immunity.

[150]  J. Hartley,et al.  Cytokine secretion in vivo and ex vivo following chemotherapy of Mycobacterium tuberculosis infection. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[151]  W. Rom,et al.  Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. , 1995, The Journal of clinical investigation.

[152]  V. Aber,et al.  The susceptibility of strains of Mycobacterium tuberculosis to catalase-mediated peroxidative killing. , 1980, Journal of general microbiology.

[153]  H. Israel,et al.  A STUDY OF TUBERCULOSIS AMONG STUDENTS OF NURSING , 1941 .

[154]  A. Izzo,et al.  Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ. , 1993, The American journal of pathology.

[155]  J. Bennedsen,et al.  Proteins released from Mycobacterium tuberculosis during growth , 1991, Infection and immunity.

[156]  H. Twigg,et al.  Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[157]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[158]  V. Aber,et al.  Phagolysosome formation, cyclic adenosine 3':5'-monophosphate and the fate of Salmonella typhimurium within mouse peritoneal macrophages. , 1979, Journal of general microbiology.

[159]  M. Newport,et al.  Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. , 1996, The New England journal of medicine.

[160]  S. Holland,et al.  Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report. , 1994, The New England journal of medicine.

[161]  T. Kwan,et al.  Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression , 1994, The Journal of experimental medicine.

[162]  L. Schlesinger.  Entry of Mycobacterium tuberculosis into mononuclear phagocytes. , 1996, Current topics in microbiology and immunology.